These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 20089984)

  • 1. Contaminated dietary supplements.
    Carvajal R
    N Engl J Med; 2010 Jan; 362(3):274; author reply 274. PubMed ID: 20089984
    [No Abstract]   [Full Text] [Related]  

  • 2. American roulette--contaminated dietary supplements.
    Cohen PA
    N Engl J Med; 2009 Oct; 361(16):1523-5. PubMed ID: 19812394
    [No Abstract]   [Full Text] [Related]  

  • 3. Injecting Safety into Supplements - Modernizing the Dietary Supplement Law.
    Cohen PA; Bass S
    N Engl J Med; 2019 Dec; 381(25):2387-2389. PubMed ID: 31851798
    [No Abstract]   [Full Text] [Related]  

  • 4. A millstone in the uphill battle for credibility.
    Czap A
    Altern Med Rev; 2001 Feb; 6(1):3. PubMed ID: 11207452
    [No Abstract]   [Full Text] [Related]  

  • 5. Dietary supplements of botanicals and other substances: a new era of regulation.
    McNamara SH
    Food Drug Law J; 1995; 50(3):341-8. PubMed ID: 10343003
    [No Abstract]   [Full Text] [Related]  

  • 6. I understand the Food and Drug Administration doesn't regulate dietary supplements as it does prescription drugs. What do I look for when shopping for vitamins and supplements?
    Mayo Clin Health Lett; 2010 Dec; 28(12):8. PubMed ID: 21229659
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of the dietary supplement health and education act on consumer beliefs about the safety and effectiveness of dietary supplements.
    Dodge T; Litt D; Kaufman A
    J Health Commun; 2011 Mar; 16(3):230-44. PubMed ID: 21120738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing supplement safety--the FDA's controversial proposal.
    Cohen PA
    N Engl J Med; 2012 Feb; 366(5):389-91. PubMed ID: 22276780
    [No Abstract]   [Full Text] [Related]  

  • 9. The federal preemption debate in pharmaceutical labeling product liability actions.
    Gross JM; Curry JA
    Tort Trial Insur Pract Law J; 2007; 43(1):35-70. PubMed ID: 18354866
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulating dietary supplement safety under the dietary supplement health and education act: brave new world or pyrrhic victory?
    Silverglade BA
    Food Drug Law J; 1996; 51(2):319-21. PubMed ID: 11822324
    [No Abstract]   [Full Text] [Related]  

  • 11. The case for preemption of prescription drug failure-to-warn claims.
    Kim CH
    Food Drug Law J; 2007; 62(2):399-422. PubMed ID: 17632969
    [No Abstract]   [Full Text] [Related]  

  • 12. The Dietary Supplement Health and Education Act.
    Young AL; Bass IS
    Food Drug Law J; 1995; 50(2):285-92. PubMed ID: 10342995
    [No Abstract]   [Full Text] [Related]  

  • 13. Compounding interest: a tragedy caused by contaminated steroids turned the spotlight on compounding pharmacies.
    Hinkley KN
    State Legis; 2013 Jun; 39(6):22-3. PubMed ID: 23805443
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulation of dietary supplement advertising: current claims of interest to the Federal Trade Commission, Food and Drug Administration and National Advertising Division.
    Villafranco JE; Lustigman AB
    Food Drug Law J; 2007; 62(4):709-25. PubMed ID: 18557227
    [No Abstract]   [Full Text] [Related]  

  • 15. Ephedra: yesterday, DSHEA, and tomorrow--a ten year perspective on the Dietary Supplement Health and Education Act of 1994.
    Seamon MJ; Clauson KA
    J Herb Pharmacother; 2005; 5(3):67-86. PubMed ID: 16520299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From herbal Prozac to Mark McGwire's tonic: how the Dietary Supplement Health and Education Act changed the regulatory landscape for health products.
    Kaczka KA
    J Contemp Health Law Policy; 2000; 16(2):463-99. PubMed ID: 10970182
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.
    Roller ST; Pippins RR; Ngai JW
    Food Drug Law J; 2009; 64(3):577-98. PubMed ID: 19999646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protecting consumers in the wake of the U.S. Dietary Supplement Health and Education Act.
    Foote JC
    J Allied Health; 2007; 36(1):57-60. PubMed ID: 17425193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary supplements: background for dialogue between the industry and the medical profession.
    Friede AI
    Food Drug Law J; 1998; 53(3):413-20. PubMed ID: 10346719
    [No Abstract]   [Full Text] [Related]  

  • 20. Should states and local governments regulate dietary supplements?
    Starr R
    Drug Test Anal; 2016; 8(3-4):402-6. PubMed ID: 26594006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.